262 related articles for article (PubMed ID: 30058012)
1. Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia.
Holubiec MI; Romero JI; Suárez J; Portavella M; Fernández-Espejo E; Blanco E; Galeano P; de Fonseca FR
Psychopharmacology (Berl); 2018 Oct; 235(10):2929-2945. PubMed ID: 30058012
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.
Fidaleo M; Fanelli F; Ceru MP; Moreno S
Curr Med Chem; 2014; 21(24):2803-21. PubMed ID: 24606520
[TBL] [Abstract][Full Text] [Related]
3. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
[TBL] [Abstract][Full Text] [Related]
4. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
Scuderi C; Valenza M; Stecca C; Esposito G; Carratù MR; Steardo L
J Neuroinflammation; 2012 Mar; 9():49. PubMed ID: 22405189
[TBL] [Abstract][Full Text] [Related]
5.
Li M; Wang D; Bi W; Jiang ZE; Piao R; Yu H
J Pharmacol Exp Ther; 2019 Apr; 369(1):163-172. PubMed ID: 30635472
[No Abstract] [Full Text] [Related]
6. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells.
Camoglio C; Balla J; Fadda P; Dedoni S
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611871
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
Citraro R; Russo E; Scicchitano F; van Rijn CM; Cosco D; Avagliano C; Russo R; D'Agostino G; Petrosino S; Guida F; Gatta L; van Luijtelaar G; Maione S; Di Marzo V; Calignano A; De Sarro G
Neuropharmacology; 2013 Jun; 69():115-26. PubMed ID: 23206503
[TBL] [Abstract][Full Text] [Related]
8. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.
Hansen HS
Exp Neurol; 2010 Jul; 224(1):48-55. PubMed ID: 20353771
[TBL] [Abstract][Full Text] [Related]
9. In vivo brain levels of acetylcholine and 5-hydroxytryptamine after oleoylethanolamide or palmitoylethanolamide administrations are mediated by PPARα engagement.
Murillo-Rodríguez E; Arankowsky-Sandoval G; Budde H; Imperatori C; Machado S; Yamamoto T; Yadollahpour A; Torterolo P
Eur J Neurosci; 2021 Sep; 54(6):5932-5950. PubMed ID: 34396611
[TBL] [Abstract][Full Text] [Related]
10. Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats.
Sayd A; Antón M; Alén F; Caso JR; Pavón J; Leza JC; Rodríguez de Fonseca F; García-Bueno B; Orio L
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548106
[TBL] [Abstract][Full Text] [Related]
11. The satiety factor oleoylethanolamide impacts hepatic lipid and glucose metabolism in goldfish.
Gómez-Boronat M; Velasco C; Isorna E; De Pedro N; Delgado MJ; Soengas JL
J Comp Physiol B; 2016 Dec; 186(8):1009-1021. PubMed ID: 27277972
[TBL] [Abstract][Full Text] [Related]
12. Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia.
Yang LC; Guo H; Zhou H; Suo DQ; Li WJ; Zhou Y; Zhao Y; Yang WS; Jin X
Biochem Pharmacol; 2015 Apr; 94(4):270-81. PubMed ID: 25748831
[TBL] [Abstract][Full Text] [Related]
13. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
[TBL] [Abstract][Full Text] [Related]
15. Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats.
Murillo-Rodríguez E; Palomero-Rivero M; Millán-Aldaco D; Arias-Carrión O; Drucker-Colín R
PLoS One; 2011; 6(7):e20766. PubMed ID: 21779318
[TBL] [Abstract][Full Text] [Related]
16. N-Oleoylethanolamine Reduces Inflammatory Cytokines and Adhesion Molecules in TNF-α-induced Human Umbilical Vein Endothelial Cells by Activating CB2 and PPAR-α.
Xu X; Guo H; Jing Z; Yang L; Chen C; Peng L; Wang X; Yan L; Ye R; Jin X; Wang Y
J Cardiovasc Pharmacol; 2016 Oct; 68(4):280-291. PubMed ID: 27281236
[TBL] [Abstract][Full Text] [Related]
17. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.
Koch M; Kreutz S; Böttger C; Benz A; Maronde E; Ghadban C; Korf HW; Dehghani F
Neurotox Res; 2011 Feb; 19(2):330-40. PubMed ID: 20221904
[TBL] [Abstract][Full Text] [Related]
18. N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism.
Okine BN; Madasu MK; McGowan F; Prendergast C; Gaspar JC; Harhen B; Roche M; Finn DP
Pain; 2016 Dec; 157(12):2687-2696. PubMed ID: 27649266
[TBL] [Abstract][Full Text] [Related]
19. Oleoylethanolamide restores alcohol-induced inhibition of neuronal proliferation and microglial activity in striatum.
Rivera P; Silva-Peña D; Blanco E; Vargas A; Arrabal S; Serrano A; Pavón FJ; Bindila L; Lutz B; Rodríguez de Fonseca F; Suárez J
Neuropharmacology; 2019 Mar; 146():184-197. PubMed ID: 30496754
[TBL] [Abstract][Full Text] [Related]
20. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
